AdaptHealth Corp. (AHCO)
NASDAQ: AHCOHealthcareMedical DevicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
AHCO stock chart
Technical analysisKey statistics
All statistics- Market cap
- $784.45M
- EPS (TTM)
- -$1.85
- Dividend yield
- None
- 52-week range
- 5.21 – 13.43
- Day range
- 5.68 – 6.05
- Volume / Avg
- 2.88M / 2.88M
- Beta
- —
- Shares outstanding
- 133.41M
- Next earnings
- Nov 3, 2026
52-week range
AHCO stock today
Shares of AdaptHealth (AHCO) finished higher on Oct 7 at $5.88, a gain of 1.91% or $0.11 per share, versus the S&P 500's 0.22% decline. Shares are 56.2% below their 52-week high of $13.43, set on May 4, 2026 and 12.9% above the 52-week low of $5.21, near the bottom of the past year's range. AHCO is down 41.0% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 34.8%.
AdaptHealth has posted a net loss over the last twelve months (EPS of -$1.85), so its P/E ratio is not meaningful. AdaptHealth's next earnings report is expected on Nov 3, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About AdaptHealth
Company profileAdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies.
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Ms. Suzanne M. Foster M.P.H.
- Headquarters
- Conshohocken, PA
- Employees
- 10,900
- IPO year
- 2018
- Website
- adapthealth.com
Analyst forecast
ForecastConsensus (7 analysts)
strong_buy
Avg. price target
$8.86+50.68%
- Strong buy 1
- Buy 6
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 3, 2026
AdaptHealth peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| VREXVarex Imaging Corporation | 18.44 | -0.22% | $783.03M | vs AHCO |
| INMDInMode Ltd. | 14.01 | +0.14% | $806.19M | vs AHCO |
| QDELQuidelOrtho Corporation | 12.31 | -2.07% | $844.16M | vs AHCO |
| PACBPacific Biosciences of California Inc. | 2.72 | +0.74% | $845.46M | vs AHCO |
| SIBNSI-BONE Inc. | 19.10 | -2.30% | $856.03M | vs AHCO |
| BVSBioventus Inc. Class A | 12.77 | -2.52% | $872.26M | vs AHCO |
| CTKBCytek Biosciences Inc. | 5.34 | -0.74% | $694.11M | vs AHCO |
| CBLLCeriBell Inc. | 23.48 | -3.53% | $901.12M | vs AHCO |
Indexes, lists and sector
Appears in lists
AdaptHealth stock FAQ
What is AdaptHealth's stock price today?
AHCO last traded at $5.88 as of Oct 7, 4:00 PM EDT, up 1.91% on the day. Prices are delayed at least 15 minutes.
When is AdaptHealth's next earnings date?
AdaptHealth is expected to report earnings on Tuesday, November 3, 2026.
Who is AdaptHealth's CEO?
Ms. Suzanne M. Foster M.P.H. is the chief executive officer of AdaptHealth Corp., which has about 10,900 employees.
What is the AHCO 52-week high?
The 52-week high for AHCO is $13.43 and the 52-week low is $5.21. The stock is currently 56.2% below its high.